331 related articles for article (PubMed ID: 9104814)
1. TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation.
Lee SY; Lee SY; Choi Y
J Exp Med; 1997 Apr; 185(7):1275-85. PubMed ID: 9104814
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction.
Park ES; Choi S; Shin B; Yu J; Yu J; Hwang JM; Yun H; Chung YH; Choi JS; Choi Y; Rho J
J Biol Chem; 2015 Apr; 290(15):9660-73. PubMed ID: 25716317
[TBL] [Abstract][Full Text] [Related]
3. CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity.
Lee SY; Lee SY; Kandala G; Liou ML; Liou HC; Choi Y
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9699-703. PubMed ID: 8790394
[TBL] [Abstract][Full Text] [Related]
4. CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2.
Tsitsikov EN; Wright DA; Geha RS
Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1390-5. PubMed ID: 9037063
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation.
Ansieau S; Scheffrahn I; Mosialos G; Brand H; Duyster J; Kaye K; Harada J; Dougall B; Hübinger G; Kieff E; Herrmann F; Leutz A; Gruss HJ
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14053-8. PubMed ID: 8943059
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor receptor (TNFR)-associated factor 2A (TRAF2A), a TRAF2 splice variant with an extended RING finger domain that inhibits TNFR2-mediated NF-kappaB activation.
Brink R; Lodish HF
J Biol Chem; 1998 Feb; 273(7):4129-34. PubMed ID: 9461607
[TBL] [Abstract][Full Text] [Related]
7. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction.
Rothe M; Xiong J; Shu HB; Williamson K; Goddard A; Goeddel DV
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8241-6. PubMed ID: 8710854
[TBL] [Abstract][Full Text] [Related]
8. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
[TBL] [Abstract][Full Text] [Related]
9. A novel domain in the CD30 cytoplasmic tail mediates NFkappaB activation.
Horie R; Aizawa S; Nagai M; Ito K; Higashihara M; Ishida T; Inoue J; Watanabe T
Int Immunol; 1998 Feb; 10(2):203-10. PubMed ID: 9533448
[TBL] [Abstract][Full Text] [Related]
10. TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase.
Hatzoglou A; Roussel J; Bourgeade MF; Rogier E; Madry C; Inoue J; Devergne O; Tsapis A
J Immunol; 2000 Aug; 165(3):1322-30. PubMed ID: 10903733
[TBL] [Abstract][Full Text] [Related]
11. ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5.
Hsu H; Solovyev I; Colombero A; Elliott R; Kelley M; Boyle WJ
J Biol Chem; 1997 May; 272(21):13471-4. PubMed ID: 9153189
[TBL] [Abstract][Full Text] [Related]
12. The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor.
Wong BR; Josien R; Lee SY; Vologodskaia M; Steinman RM; Choi Y
J Biol Chem; 1998 Oct; 273(43):28355-9. PubMed ID: 9774460
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation.
Aizawa S; Nakano H; Ishida T; Horie R; Nagai M; Ito K; Yagita H; Okumura K; Inoue J; Watanabe T
J Biol Chem; 1997 Jan; 272(4):2042-5. PubMed ID: 8999898
[TBL] [Abstract][Full Text] [Related]
14. CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival.
Duckett CS; Thompson CB
Genes Dev; 1997 Nov; 11(21):2810-21. PubMed ID: 9353251
[TBL] [Abstract][Full Text] [Related]
15. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily.
Galibert L; Tometsko ME; Anderson DM; Cosman D; Dougall WC
J Biol Chem; 1998 Dec; 273(51):34120-7. PubMed ID: 9852070
[TBL] [Abstract][Full Text] [Related]
16. Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase.
Kim HH; Lee DE; Shin JN; Lee YS; Jeon YM; Chung CH; Ni J; Kwon BS; Lee ZH
FEBS Lett; 1999 Jan; 443(3):297-302. PubMed ID: 10025951
[TBL] [Abstract][Full Text] [Related]
17. Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins.
Takeuchi M; Rothe M; Goeddel DV
J Biol Chem; 1996 Aug; 271(33):19935-42. PubMed ID: 8702708
[TBL] [Abstract][Full Text] [Related]
18. An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway.
Morrison MD; Reiley W; Zhang M; Sun SC
J Biol Chem; 2005 Mar; 280(11):10018-24. PubMed ID: 15644327
[TBL] [Abstract][Full Text] [Related]
19. Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2.
Duckett CS; Gedrich RW; Gilfillan MC; Thompson CB
Mol Cell Biol; 1997 Mar; 17(3):1535-42. PubMed ID: 9032281
[TBL] [Abstract][Full Text] [Related]
20. Expression of the tumor necrosis factor receptor-associated factors 1 and 2 and regulation of the nuclear factor-kappaB antiapoptotic activity in human gliomas.
Conti A; Ageunnouz M; La Torre D; Cardali S; Angileri FF; Buemi C; Tomasello C; Iacopino DG; D'Avella D; Vita G; Tomasello F
J Neurosurg; 2005 Nov; 103(5):873-81. PubMed ID: 16304992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
